Evidence map›Paper›PMID 21795434›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2011

Bromoenol lactone inhibits voltage-gated Ca2+ and transient receptor potential canonical channels.

Saikat Chakraborty, Zachary C Berwick, Paula J Bartlett, Sanjay Kumar, Andrew P Thomas, Michael Sturek, Johnathan D Tune, Alexander G Obukhov

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Small-molecule CaProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mitochondrial reactive oxygen species: which ROS signals cardioprotection?American journal of physiology. Heart and circulatory physiology · 2013
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Saikat ChakrabortyDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indiana University-Purdue University Indianapolis, 635 Barnhill Dr., MS360A, Indianapolis, IN 46202, USA.
Zachary C Berwick
Paula J Bartlett
Sanjay Kumar
Andrew P Thomas
Michael Sturek
Johnathan D Tune
Alexander G Obukhov
Indiana University – Purdue University Indianapolis · USLaboratoire d’immunologie intégrative du cancer · FRRutgers, The State University of New Jersey · US

Funding

Molecular Physiology of TRPC ChannelsR01HL083381 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI OBUKHOV, ALEXANDER G. · 2006 to 2010
$1.8M
NHLBI NIH HHS HL083381NHLBI NIH HHS R01 HL083381
6 · The paper itself

Abstract

Circulating hormones stimulate the phospholipase Cβ (PLC)/Ca(2+) influx pathway to regulate numerous cell functions, including vascular tone. It was proposed previously that Ca(2+)-independent phospholipase A(2) (iPLA(2))-dependent store-operated Ca(2+) influx channels mediate hormone-induced contractions in isolated arteries, because bromoenol lactone (BEL), a potent irreversible inhibitor of iPLA(2), inhibited such contractions. However, the effects of BEL on other channels implicated in mediating hormone-induced vessel contractions, specifically voltage-gated Ca(2+) (Ca(V)1.2) and transient receptor potential canonical (TRPC) channels, have not been defined clearly. Using isometric tension measurements, we found that thapsigargin-induced contractions were ∼34% of those evoked by phenylephrine or KCl. BEL completely inhibited not only thapsigargin- but also phenylephrine- and KCl-induced ring contractions, suggesting that Ca(V)1.2 and receptor-operated TRPC channels also may be sensitive to BEL. Therefore, we investigated the effects of BEL on heterologously expressed Ca(V)1.2 and TRPC channels in human embryonic kidney cells, a model system that allows probing of individual protein function without interference from other signaling elements of native cells. We found that low micromolar concentrations of BEL inhibited Ca(V)1.2, TRPC5, TRPC6, and heteromeric TRPC1-TRPC5 channels in an iPLA(2)-independent manner. BEL also attenuated PLC activity, suggesting that the compound may inhibit TRPC channel activity in part by interfering with an initial PLC-dependent step required for TRPC channel activation. Conversely, BEL did not affect endogenous voltage-gated K(+) channels in human embryonic kidney cells. Our findings support the hypothesis that iPLA(2)-dependent store-operated Ca(2+) influx channels and iPLA(2)-independent hormone-operated TRPC channels can serve as smooth muscle depolarization triggers to activate Ca(V)1.2 channels and to regulate vascular tone.

Indexed as

AnimalsBehavior, AddictiveCalcium ChannelsCarbazolesCocaineConditioning, OperantDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsDose-Response Relationship, DrugHumansMaleNaphthalenesPhosphodiesterase InhibitorsPhospholipasesPyronesRadioligand Assay6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-oneCalcium ChannelsCarbazolesCocaineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsNaphthalenesPhosphodiesterase InhibitorsPhospholipasesPyronesReceptors, sigmarimcazoleThapsigarginTransient Receptor Potential Channels

Identifiers

PMID21795434
PMCPMC3199998
OpenAlexW2125509912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.